Sign In
Buy CSTL
$20.39
+0.680 (+3.45%)
At Close: Jun 03, 2026
Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable
09:56am, Friday, 21'st Nov 2025
Castle Biosciences (CSTL) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
5 Stocks With Recent Price Strength Amid Wall Street Volatility
09:51am, Thursday, 20'th Nov 2025
CSTL, IDN, PANL, FSRL and PRM are showing sharp price strength amid renewed Wall Street volatility.
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year
07:00am, Monday, 17'th Nov 2025
FRIENDSWOOD, Texas, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has
Forget the Fed, Bet on These 4 Stocks With Increasing Cash Flows
08:41am, Friday, 14'th Nov 2025
Four rising cash-flow stocks, including PRM, TILE, CSTL and GLDD, stand out with upgraded earnings estimates and strong VGM scores.
Castle will present new data showing the clinical value of DecisionDx-Melanoma in improving sentinel lymph node biopsy decision making at Dermato-Onco2025.
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference
07:00am, Tuesday, 11'th Nov 2025
Castle Biosciences' executive management will present a company overview at the Piper Sandler 37th Annual Healthcare Conference on 12/2/25 at 1:10pm ET
4 Stocks With Recent Price Strength to Enhance Your Portfolio
02:46am, Tuesday, 11'th Nov 2025
Four stocks, CSTL, PRM, SABK and ATRO show recent gains, signaling potential momentum plays for investors in 2025.
Recent Price Trend in Castle Biosciences (CSTL) is Your Friend, Here's Why
01:41pm, Wednesday, 05'th Nov 2025
Castle Biosciences (CSTL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thr
Why Castle Biosciences' Rally Might Just Be Getting Started
08:02am, Wednesday, 05'th Nov 2025
Castle Biosciences (NASDAQ:CSTL) rallied more than 20% after delivering a strong Q3 performance. When analyzed through the lens of the Adhishthana Principles, the stock shows clear signs of momentum b
Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript
11:06pm, Monday, 03'rd Nov 2025
Castle Biosciences, Inc. ( CSTL ) Q3 2025 Earnings Call November 3, 2025 4:30 PM EST Company Participants Camilla Zuckero - Vice President of Investor Relations & Corporate Affairs Derek Maetzold - Fo
Castle Biosciences Reports Third Quarter 2025 Results
04:07pm, Monday, 03'rd Nov 2025
Delivered Q3 2025 revenue of $83 million Q 3 2025 non-dermatologic revenue increased by 67% over Q 3 2024 Q 3 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, TissueCyphe
FRIENDSWOOD, Texas, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the launch o
Castle Biosciences (CSTL) Expected to Announce Quarterly Earnings on Monday
02:00am, Saturday, 01'st Nov 2025
Castle Biosciences (NASDAQ: CSTL - Get Free Report) will likely be posting its Q3 2025 results after the market closes on Monday, November 3rd. Analysts expect Castle Biosciences to post earnings of (
Forget Profit, Pick These 4 Stocks With Increasing Cash Flows
01:06pm, Thursday, 30'th Oct 2025
Amid earnings buzz, stocks like RadNet, Mission Produce, Castle Biosciences and FreightCar America stand out for their rising cash flows and resilience.
Castle Biosciences to Participate in Upcoming Investor Conferences
07:00am, Tuesday, 28'th Oct 2025
FRIENDSWOOD, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its exe
